meperidine has been researched along with tamoxifen in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Sen, S; Sinha, N | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Cabot, MC; Cao, Ht; Geffen, V; Giuliano, AE; Han, TY; Lavie, Y; Lucci, A; Volner, A | 1 |
| Banerjee, S; Basu, M; Basu, S; Boyle, PJ; Bradley, M; Ma, R; Mikulla, B; Smith, B | 1 |
| Altinoz, MA; Hacker, E; Ozpinar, A | 1 |
2 review(s) available for meperidine and tamoxifen
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
A hypothetical proposal to employ meperidine and tamoxifen in treatment of glioblastoma. Role of P-glycoprotein, ceramide and metabolic pathways.
Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Ceramides; Glioblastoma; Humans; Meperidine; Metabolic Networks and Pathways; N-Methylaspartate; Tamoxifen | 2022 |
6 other study(ies) available for meperidine and tamoxifen
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells.
Topics: Ceramides; Cyclosporine; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Glycosphingolipids; Glycosylation; Humans; Meperidine; Tamoxifen; Tumor Cells, Cultured; Verapamil | 1997 |
Apoptosis of human carcinoma cells in the presence of potential anti-cancer drugs: III. Treatment of Colo-205 and SKBR3 cells with: cis -platin, Tamoxifen, Melphalan, Betulinic acid, L-PDMP, L-PPMP, and GD3 ganglioside.
Topics: Antineoplastic Agents; Apoptosis; Betulinic Acid; Caspase 3; Caspases; Cell Line, Tumor; Cell Nucleus; Cisplatin; DNA; DNA Helicases; DNA Polymerase I; Dose-Response Relationship, Drug; Electrophoresis, Agar Gel; Fluorescent Dyes; Gangliosides; Glycosphingolipids; Humans; Melphalan; Meperidine; Microscopy, Fluorescence; Models, Biological; Models, Chemical; Morpholines; Pentacyclic Triterpenes; Propidium; Signal Transduction; Sphingolipids; Tamoxifen; Time Factors; Triterpenes; Zinc Fingers | 2004 |